Skip to Content

Rimrock Gold Corp RMRK

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RMRK is trading at a 766% premium.
Price
$0.00
Fair Value
$2.38
Uncertainty
Extreme
1-Star Price
$5.77
5-Star Price
$4.48
Economic Moat
Kft
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RMRK is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$1.15 Mil
Volume/Avg
1.2 Mil / 3.3 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Rimrock Gold Corp is engaged in research, development, and sales of unique CBD products such as CBD oils and hemp extracts on a large scale. the company acquired Hemp Tradition, LLC through its wholly owned subsidiary Acqua Cannabis. and also looking forward to more acquisitions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
2

Valuation

Metric
RMRK
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
RMRK
Quick Ratio
0.01
Current Ratio
0.01
Interest Coverage
−2.22
Quick Ratio
RMRK

Profitability

Metric
RMRK
Return on Assets (Normalized)
−182.34%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−217.67%
Return on Assets
RMRK
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
PbxmgblwnFffm$81.7 Bil
Merck KGaA ADR
MKKGY
GvfnlccmpwWwbsnsj$72.9 Bil
Haleon PLC ADR
HLN
PwvjjwprZbwxn$39.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
WmgjswlkLhwk$13.4 Bil
Viatris Inc
VTRS
SnkqxcfGxxxg$13.4 Bil
Catalent Inc
CTLT
RgbcldcyVhzyhg$10.4 Bil
Perrigo Co PLC
PRGO
DrsvrvygXzzm$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
HhgdmdhFdqrzvt$3.5 Bil
Curaleaf Holdings Inc
CURLF
WbxtqsdvVbbx$3.1 Bil
Green Thumb Industries Inc
GTBIF
RjcjxxfqmDrgqr$2.8 Bil

Sponsor Center